Thrombotic Risk Detection in Patients with Polycythemia Vera: The Predictive Role of DNMT3A/TET2/ASXL1 Mutations

The development of thrombotic events is common among patients with polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). We studied the influence of pathogenic mutations frequently associated with myeloid malignancies on thrombotic events using next-generation sequ...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancers (Basel)
Auteurs principaux: Segura-Díaz, Adrián, Stuckey, Ruth, Florido, Yanira, González-Martín, Jesús María, López-Rodríguez, Juan Francisco, Sánchez-Sosa, Santiago, González-Pérez, Elena, Perdomo, María Nieves Sáez, Perera, María del Mar, de la Iglesia, Silvia, Molero-Labarta, Teresa, Gómez-Casares, María Teresa, Bilbao-Sieyro, Cristina
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7226609/
https://ncbi.nlm.nih.gov/pubmed/32290079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12040934
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires